PL375726A1 - Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia - Google Patents

Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia

Info

Publication number
PL375726A1
PL375726A1 PL03375726A PL37572603A PL375726A1 PL 375726 A1 PL375726 A1 PL 375726A1 PL 03375726 A PL03375726 A PL 03375726A PL 37572603 A PL37572603 A PL 37572603A PL 375726 A1 PL375726 A1 PL 375726A1
Authority
PL
Poland
Prior art keywords
bulimia
epa
eicosapentaenoic acid
anorexia nervosa
treating anorexia
Prior art date
Application number
PL03375726A
Other languages
English (en)
Polish (pl)
Inventor
David Frederick Horrobin
Agnes Ayton
Original Assignee
Amarin Neuroscience Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9944164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL375726(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amarin Neuroscience Limited filed Critical Amarin Neuroscience Limited
Publication of PL375726A1 publication Critical patent/PL375726A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL03375726A 2002-09-16 2003-09-16 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia PL375726A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0221480.7A GB0221480D0 (en) 2002-09-16 2002-09-16 Treatment of anorexia nervosa (AN) and bulimia

Publications (1)

Publication Number Publication Date
PL375726A1 true PL375726A1 (en) 2005-12-12

Family

ID=9944164

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03375726A PL375726A1 (en) 2002-09-16 2003-09-16 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia

Country Status (20)

Country Link
US (1) US20060135608A1 (OSRAM)
EP (1) EP1556028A1 (OSRAM)
JP (1) JP2006503031A (OSRAM)
KR (1) KR20050042823A (OSRAM)
CN (1) CN1694694A (OSRAM)
AU (1) AU2003269138A1 (OSRAM)
BR (1) BR0317857A (OSRAM)
CA (1) CA2499142A1 (OSRAM)
GB (1) GB0221480D0 (OSRAM)
HR (1) HRP20050245A2 (OSRAM)
IS (1) IS7744A (OSRAM)
MX (1) MXPA05002943A (OSRAM)
NO (1) NO20051847L (OSRAM)
NZ (1) NZ538793A (OSRAM)
PL (1) PL375726A1 (OSRAM)
RS (1) RS20050226A (OSRAM)
RU (1) RU2330653C2 (OSRAM)
TW (1) TW200410682A (OSRAM)
WO (1) WO2004024136A1 (OSRAM)
ZA (1) ZA200502161B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003048831A (ja) 2001-08-02 2003-02-21 Suntory Ltd 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
CA2545190A1 (en) * 2003-11-14 2005-05-26 Mochida Pharmaceutical Co., Ltd. Agent for preventing and treating language disorders
JP4993852B2 (ja) 2004-09-17 2012-08-08 サントリーホールディングス株式会社 ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP5967855B2 (ja) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
US8383677B2 (en) 2006-12-28 2013-02-26 Suntory Holdings Limited Nerve-regenerating agent
EP2121576B1 (en) 2007-02-15 2015-11-11 Centre De Recherche Sur Les Biotechnologies Marine Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
US8816110B2 (en) 2007-02-15 2014-08-26 Scf Pharma Inc. Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
WO2008113177A1 (en) 2007-03-20 2008-09-25 Centre De Recherche Sur Les Biotechnologies Marines Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CA3129996C (en) * 2009-06-15 2025-09-02 Amarin Pharmaceuticals Ireland Limited COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES WITHOUT RAISED LDL-C LEVELS IN A SUBJECT UNDERGOING CONCOMITANT STATIN THERAPY
WO2012109539A1 (en) * 2011-02-11 2012-08-16 E. I. Du Pont De Nemours And Company An eicosapentaenoic acid concentrate
US9447020B2 (en) 2013-10-31 2016-09-20 Scf Pharma Inc. Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
RU2545988C1 (ru) * 2013-11-12 2015-04-10 Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы Способ лечения хронического запора и функциональной анорексии
CN111971041A (zh) 2018-02-07 2020-11-20 Scf制药股份有限公司 多不饱和脂肪酸单甘油酯、组合物、方法及其用途
WO2019204218A1 (en) * 2018-04-16 2019-10-24 Quadrant Biosciences Inc. Salivary microrna levels in anorexia nervosa provide a liquid biopsy of metabolic and neuropsychiatric status
AU2019264159A1 (en) 2018-05-03 2020-12-24 Scf Pharma Inc. Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof
CN109276262B (zh) * 2018-07-30 2021-01-26 中国科学院心理研究所 一种用于筛选高危进食障碍的检测系统
US12226390B2 (en) 2019-07-21 2025-02-18 Scf Pharma Inc. Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof
CA3173641A1 (en) * 2020-03-27 2021-09-30 Barbara SCOLNICK Method of treatment for anorexia nervosa, bulimia and related clinical syndromes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
GB9901809D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes

Also Published As

Publication number Publication date
JP2006503031A (ja) 2006-01-26
MXPA05002943A (es) 2005-06-03
US20060135608A1 (en) 2006-06-22
TW200410682A (en) 2004-07-01
RU2330653C2 (ru) 2008-08-10
WO2004024136A1 (en) 2004-03-25
BR0317857A (pt) 2005-12-06
NO20051847L (no) 2005-04-15
CA2499142A1 (en) 2004-03-25
IS7744A (is) 2005-03-15
EP1556028A1 (en) 2005-07-27
RU2005107416A (ru) 2006-01-20
NZ538793A (en) 2007-05-31
AU2003269138A1 (en) 2004-04-30
ZA200502161B (en) 2005-09-15
RS20050226A (sr) 2007-09-21
HRP20050245A2 (en) 2005-10-31
KR20050042823A (ko) 2005-05-10
GB0221480D0 (en) 2002-10-23
CN1694694A (zh) 2005-11-09

Similar Documents

Publication Publication Date Title
PL375726A1 (en) Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia
AU2003262763A8 (en) Method and apparatus for adaptive power consumption
AU2003247624A8 (en) Method of treating the syndrome of lipodystrophy
AU2001275795A1 (en) Electrochemical treating method such as electroplating and electrochemical reaction device therefor
GB0319464D0 (en) Apparatus and method for electrochemical cell components
GB2378043B (en) Method for the fabrication of electrical contacts
AU2003285140A8 (en) Apparatus for providing high quality power
EP1313042A4 (en) METHOD FOR ELECTRONIC SETTLEMENT USING A MOBILE TERMINAL
IL159376A (en) Apparatus for acne treatment
AU2003304722A1 (en) Method for treating waste-activated sludge using elecroporation
IL165304A0 (en) Method of treating diabetes
AU2003257620A1 (en) Substrate treating apparatus
PL375742A1 (en) Method of treating osteoarthritis
GB2396983B (en) Circuit apparatus operable under high voltage
GB0212933D0 (en) Electrical discharge machining apparatus
PL376932A1 (pl) Sposób traktowania żużla
GB0325371D0 (en) Method and apparatus for the manufacture of electric circuits
HK1076027A (en) Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia
AUPR437601A0 (en) Process for sulphide concentration
PL376350A1 (en) Sludge treatment method
AU2003237593A8 (en) Process for the preparation of 4-(4-fluorobenzoyl) butyric acid
GB0112235D0 (en) The treatment of anorexia nervosa
SG98083A1 (en) Method of improving the quality of soldered connections
GB0201472D0 (en) Method and apparatus for mediated electrochemical redox reaction
EP1391223A4 (en) PCB PROCESSING DEVICE AND ELECTROLYSIS PCB PROCESSING METHOD

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)